Influenza virus characterisation, summary Europe, July 2011

Surveillance report
Since the last influenza virus characterisation report, 250 virus specimens collected from February to June 2011 have been received from EU and EU-affiliated countries.

Executive Summary

More specifically, Influenza A(H1N1)pdm, influenza A(H3N2), and influenza B/Victoria- and B/Yamagata-lineage viruses have been characterised genetically and antigenically. Some of the findings are:

  • Recently isolated A(H1N1)pdm viruses continue to fall into several genetic groups but all groups show antigenic similarity to the currently recommended vaccine virus A/California/7/2009.
  • A(H3N2) viruses fall into distinct genetic groups but there is no consistent correlation of altered antigenicity with any genetic group, compared with the vaccine virus A/Perth/16/2009.
  • Influenza B viruses of the B/Victoria/2/87 lineage predominate over those of the B/Yamagata/16/88 lineage. Most of the B/Victoria/2/87 lineage viruses remain genetically and antigenically similar to the currently recommended vaccine virus B/Brisbane/60/2008.
  • The majority of influenza B viruses of the B/Yamagata-lineage are in the B/Bangladesh/3333/2007 genetic clade but viruses received from three countries with Baltic coastlines fall within a different genetic clade.
Publication file

1108_SUR_Influenza_virus_characterisation_July.pdf

English (1.82 MB - PDF)

Share this page